Editorial: Drug Development and Target Discovery in Pulmonary Vascular Diseases

Front Pharmacol. 2020 May 8:11:660. doi: 10.3389/fphar.2020.00660. eCollection 2020.

Authors

Rui Zhang¹, Yang-Yang He², Zhi-Cheng Jing^{1

2}

Affiliations

¹ Department of Cardio-Pulmonary Circulation, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
² Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

No abstract available

Keywords: drug development; molecular machine; pulmonary arterial hypertension; pulmonary vascular disease; targeted drug.

Publication types

Editorial